Health Care: Drugs

Actavis PLC (ACT: NYSE)

$312.43 5.64 | 1.84%
05/28/15 - 02:11 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
ACTSector Avg.S&P 500
n/a026.72
Price Performance History (% change):
3 Mo1 Yr3 Yr
5.295943.12570
GROWTH12 Mo3 YrCAGR
Revenue50.51.850.41
Net Income-7.290
EPS-4.53n/a
Earnings for ACT:
EBITDA3.40B
REVENUE13.06B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $4.45 $4.40 $17.84 $21.40
Number of Analysts 4 4 11 8
High Estimate $4.65 $4.52 $18.13 $22.04
Low Estimate $4.30 $4.25 $17.25 $20.61
Prior Year $3.42 $3.19 $13.98 $17.84
Growth Rate (Year over Year) 30.12% 37.93% 27.60% 19.98%

Portfolios with ACT

Latest ACT Headlines from TheStreet

More Financial News for ACT

Press Releases for ACT

See All Press Releases

Partner Headlines for ACT

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter